The clinicopathological evaluation of the breast cancer patients with brain metastases: predictors of survival
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The clinicopathological evaluation of the breast cancer patients with brain metastases: predictors of survival
Authors
Keywords
Breast cancer, Brain metastases, Tumor subtypes, Clinical outcome
Journal
CLINICAL & EXPERIMENTAL METASTASIS
Volume 30, Issue 2, Pages 201-213
Publisher
Springer Nature
Online
2012-08-22
DOI
10.1007/s10585-012-9528-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characteristics of Breast Cancer Patients with Central Nervous System Metastases: A Single-Center Experience
- (2015) Hakan Harputluoglu et al. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
- Brain metastases free survival differs between breast cancer subtypes
- (2012) A Berghoff et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2011
- (2011) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Central Nervous System Metastases in Patients with HER2-Positive Metastatic Breast Cancer: Incidence, Treatment, and Survival in Patients from registHER
- (2011) A. M. Brufsky et al. CLINICAL CANCER RESEARCH
- Triple-negative breast cancer with brain metastases: a comparison between basal-like and non-basal-like biological subtypes
- (2011) Anna Niwińska et al. JOURNAL OF NEURO-ONCOLOGY
- Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment
- (2011) Hee-Jun Kim et al. JOURNAL OF NEURO-ONCOLOGY
- The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases
- (2010) Carey K. Anders et al. CANCER
- Clinical Outcomes and Breast Cancer Subtypes in Patients with Brain Metastases
- (2010) Hyuk-Chan Kwon et al. ONKOLOGIE
- Survival among women with triple receptor-negative breast cancer and brain metastases
- (2009) S. Dawood et al. ANNALS OF ONCOLOGY
- Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT)
- (2009) A. Niwinska et al. ANNALS OF ONCOLOGY
- Patterns of relapse in breast cancer: changes over time
- (2009) Rinat Yerushalmi et al. BREAST CANCER RESEARCH AND TREATMENT
- Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients
- (2009) Y H Park et al. BRITISH JOURNAL OF CANCER
- Patterns of relapse and metastatic spread in HER2-overexpressing breast cancer according to estrogen receptor status
- (2009) Yeon Hee Park et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases
- (2009) Florian Heitz et al. EUROPEAN JOURNAL OF CANCER
- Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer
- (2008) Nancy U. Lin et al. CANCER
- Survival in patients with brain metastases from breast cancer
- (2008) April F. Eichler et al. CANCER
- Subtypes of Breast Cancer Show Preferential Site of Relapse
- (2008) M. Smid et al. CANCER RESEARCH
- Central Nervous System Metastases in HER-2-Overexpressing Metastatic Breast Cancer: A Treatment Challenge
- (2008) H.-J. Stemmler et al. ONCOLOGIST
- The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER2
- (2008) Aleix Prat et al. Nature clinical practice. Oncology
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started